Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. Early life. Collis was born in South Africa and attended the University of Witwatersrand, where he earned a Bachelor of Commerce. Collis is Jewish. Career
May 24, 2024 at 3:01 PM. (Reuters) -U.S. drug distributor Cencora has notified affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and ...
File:AmerisourceBergen logo.svg. Size of this PNG preview of this SVG file: 800 × 218 pixels. Other resolutions: 320 × 87 pixels | 640 × 174 pixels | 1,024 × 279 pixels | 1,280 × 349 pixels | 2,560 × 698 pixels. Original file (SVG file, nominally 1,024 × 279 pixels, file size: 14 KB) This is a file from the Wikimedia Commons.
2007. Free Cash Flow. $1.5 billion. $859 million. $900 million. $380 million. $710 million. Source: S&P Capital IQ. Now we know how much cash AmerisourceBergen is really pulling in each year.
It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...
This page was last edited on 31 August 2023, at 09:27 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...
For premium support please call: 800-290-4726 more ways to reach us